Old Web
English
Sign In
Acemap
>
authorDetail
>
Maria Bloisi
Maria Bloisi
Virology
Biology
Nat
human immunodeficiency virus
Standardization
4
Papers
66
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (<1,000 copies/milliliter): comparison with clinical samples and NIBSC working reagent for nucleic acid testing assays.
2014
Journal of Clinical Microbiology
Alessandra Amendola
Patrizia Marsella
Maria Bloisi
Federica Forbici
Claudio Angeletti
Maria Rosaria Capobianchi
Show All
Source
Cite
Save
Citations (28)
Focus on the ability to quantify low HIV-1 RNA levels (<1000 copies/ml) by two commercially available assays (Abbott Real-time HIV-1 and the Roche COBAS Ampliprep/COBAS TaqMan HIV-1 v2.0): comparison with clinical samples and NIBSC Working Reagent for NAT assays.
2014
Journal of Clinical Microbiology
Alessandra Amendola
Patrizia Marsella
Maria Bloisi
Federica Forbici
Claudio Angeletti
Maria Rosaria Capobianchi
Show All
Source
Cite
Save
Citations (20)
Erratum to “Standardization and performance evaluation of “modified” and “ultrasensitive” versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia” [J. Clin. Virol. 52 (2011) 17–22]
2012
Journal of Clinical Virology
Alessandra Amendola
Maria Bloisi
Patrizia Marsella
Rosella Sabatini
Angela Bibbò
Claudio Angeletti
Maria Rosaria Capobianchi
Show All
Source
Cite
Save
Citations (0)
Standardization and performance evaluation of “modified” and “ultrasensitive” versions of the Abbott RealTime HIV-1 assay, adapted to quantify minimal residual viremia
2011
Journal of Clinical Virology
Alessandra Amendola
Maria Bloisi
Patrizia Marsella
Rosella Sabatini
Angela Bibbò
Claudio Angeletti
Maria Rosaria Capobianchi
Show All
Source
Cite
Save
Citations (18)
1